Since 2016, Karah Parschauer has served as EVP, General Counsel and Secretary to the Board of Directors for Ultragenyx Pharmaceutical, a publicly traded biotechnology company focused on the treatment of rare genetic diseases. In this role, she is responsible for leading the company’s legal, compliance, and government affairs functions. Before joining Ultragenyx, Ms. Parschauer spent 11 years at Allergan, most recently as Vice President, Associate General Counsel. Prior to joining Allergan, Ms. Parschauer was an Associate Attorney at Latham & Watkins LLP. Ms. Parschauer has a Bachelor of Arts from Miami University and a Juris Doctor from Harvard Law School.